Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil as Adjuvant to Bupivacaine in Supraclavicular Block
NCT06847620Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Mar 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of verapamil in postoperative pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Duration from giving the block till the need of rescue analgesia at 24 hours. Started Mar 2024; status: completed.
02
Drugs
verapamil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06847620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06847620.